LUTONIX 035
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LUTONIX 035, covering 2020-05-22 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon [NA]